Uterine Cervical Dysplasia
"Uterine Cervical Dysplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.
Descriptor ID |
D002578
|
MeSH Number(s) |
C04.834.818 C13.351.500.852.593.074
|
Concept/Terms |
Uterine Cervical Dysplasia- Uterine Cervical Dysplasia
- Cervical Dysplasia, Uterine
- Dysplasia, Uterine Cervical
- Cervix Dysplasia
- Dysplasia, Cervix
|
Below are MeSH descriptors whose meaning is more general than "Uterine Cervical Dysplasia".
Below are MeSH descriptors whose meaning is more specific than "Uterine Cervical Dysplasia".
This graph shows the total number of publications written about "Uterine Cervical Dysplasia" by people in this website by year, and whether "Uterine Cervical Dysplasia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2000 | 0 | 1 | 1 |
2001 | 1 | 1 | 2 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 4 | 0 | 4 |
2006 | 1 | 0 | 1 |
2009 | 3 | 0 | 3 |
2011 | 1 | 0 | 1 |
2014 | 2 | 0 | 2 |
2015 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uterine Cervical Dysplasia" by people in Profiles.
-
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol. 2015 Feb; 125(2):330-337.
-
Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population. Am J Clin Pathol. 2015 Jan; 143(1):126-33.
-
Comparison of the Aptima and Cervista tests for detection of high-risk human papillomavirus in cervical cytology specimens. Am J Clin Pathol. 2014 Oct; 142(4):561-6.
-
Cost-effectiveness analysis of 2 surveillance options for cervical intraepithelial neoplasia 1. J Low Genit Tract Dis. 2014 Apr; 18(2):136-41.
-
Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Am J Clin Pathol. 2011 Feb; 135(2):212-20.
-
HSIL pap test and risk factors predicting acquisition of CIN 2/3 on colposcopy-directed biopsies. J S C Med Assoc. 2009 Dec; 105(7):281-6.
-
Knowledge, beliefs, and attitudes related to human papillomavirus infection and vaccination, pap tests, and cervical intraepithelial neoplasia among adolescent girls and young women. J S C Med Assoc. 2009 Dec; 105(7):267-72.
-
Management of the low grade squamous intraepithelial lesion Pap smear in a cross-sectional, observational cohort. J Reprod Med. 2009 Jul; 54(7):421-4.
-
Cyclooxygenase-2 in cervical neoplasia: a review. Gynecol Oncol. 2008 Apr; 109(1):140-5.
-
Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-103.